Cita APA

Van Cutsem, E., Yaeger, R., Delord, J., Tabernero, J., Siu, L. L., Ducreux, M., . . . Wainberg, Z. A. (2023). Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.

Citación estilo Chicago

Van Cutsem, Eric|||0000-0002-6372-1230, et al. Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer. 2023.

Cita MLA

Van Cutsem, Eric|||0000-0002-6372-1230, et al. Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer. 2023.